Mariner, LLC Immunocore Holdings PLC Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$33.78 - $63.75 $50,129 - $94,605	1,484 Added 26.24%	7,139 $241,000
Q1 2024 May 15, 2024	BUY	$60.14 - $75.36 $21,951 - $27,506	365 Added 6.9%	5,655 $367,000
Q4 2023 Feb 14, 2024	BUY	$42.85 - $69.5 $41,093 - $66,650	959 Added 22.14%	5,290 $361,000
Q3 2023 Nov 13, 2023	BUY	$49.5 - $66.6 $29,650 - $39,893	599 Added 16.05%	4,331 $224,000
Q2 2023 Aug 11, 2023	BUY	$48.54 - $61.64 $181,151 - $230,040	3,732 New	3,732 $223,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.